620.80
-2.30%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Solara Active Pharma Sciences Ltd. is trading above its 150 day SMA of 574.5
More from Solara Active Pharma Sciences Ltd.
Recommended